ISTA Pharmaceuticals' New Drug Application for Bepreve Accepted for Review by U.S. Food and Drug Administration

ISTA Pharmaceuticals, Inc. today announced that ISTA's New Drug Application for Bepreve (bepotastine ophthalmic solution) has been accepted for review by the U.S. FDA.

The details can be read here.